• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Golden retrievers sought for long-term MAF study

October 24, 2012

Investigators ask DVMs, pet owners to enroll dogs in lifetime health project.

Owners of golden retrievers, along with their veterinarians, have an opportunity to improve the health of future generations of dogs, thanks to a study being conducted by Morris Animal Foundation (MAF). According to the nonprofit organization, 3,000 dogs will be enrolled over the next two years to participate in the Golden Retriever Lifetime Study, the largest and longest observational study ever launched in an effort to better understand the genetic, nutritional and environmental risk factors for cancers and other canine diseases.

Dogs must be in good health and less than 2 years of age to be considered for enrollment. In addition, participants are required to commit to the study for the entire life of their dog.

According to study director Michael Guy, DVM, PhD, dogs that meet the initial criteria for participation must go through a comprehensive screening process in order to be considered for the study. Additionally, pet owners will fill out a questionnaire on their dog’s history, which covers topics such as diet, reproduction, environment and travel. If accepted into the study, laboratory tests and physical exams are repeated annually, in addition to the owner questionnaire.

Guy states that one of the main goals of the study is to look at the incidence of four major types of cancer--hemangiosarcoma, lymphoma, osteosarcoma and mast cell tumors--commonly seen in golden retrievers and other breeds. “We expect that over the lifetime of this study, when these dogs approach 10 to 12 years of age, somewhere in the range of 500 participants will have presented with these types of tumors,” Guy says.

Response to the study has been positive, says Guy, who states that since enrollment opened, more than 400 golden retrievers have been approved to participate the study based on the initial screening results.

Advertisement

The study has also received significant support from sponsors such as the Morris family, the Blue Buffalo Foundation for Cancer Research, Hill’s Pet Nutrition, Petco, Pfizer Animal Health and VCA Antech, which collectively have contributed more than $18 million toward the project. Additional sponsors include the Hadley and Marion Stuart Foundation and Mars Veterinary.

The study was first announced at the North American Veterinary Conference in 2011 and is the first of its kind in the Canine Lifetime Health Project (CLHP). “CLHP is the umbrella for the research we’re doing,” says Guy. At present time, the Golden Retriever Lifetime Study is the only study under way, but Guy expects that in the future, a number of studies will be running simultaneously.

Owners interested in participating can register their dogs at CanineLifetimeHealth.org.

Related Content:

Medical
3 Must-reads for National Poison Prevention Week
3 Must-reads for National Poison Prevention Week
UC Davis study on eye diseases in kittens
UC Davis study on eye diseases in kittens
Dr Natalie Marks to lecture on diabetes management with Dr Adam Christman
Dr Natalie Marks to lecture on diabetes management with Dr Adam Christman

Advertisement

Latest News

Xylazine moves from the stables to the streets

DEA reports widespread threat of fentanyl mixed with xylazine

3 Must-reads for National Poison Prevention Week

UC Davis study on eye diseases in kittens

View More Latest News
Advertisement